Filed: 11/3/2023ACC: 0000950123-23-009395
📋 What this filing means
VERSANT VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $188.11M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$188.11M
Total AUM (reported)
24.30M
Total Shares
Allocation by class
COMMON STOCK$165.48M88.0%
COMMON SHARES$22.63M12.0%
Portfolio Concentration
Top 3$169.11M89.9%
4–10$19.00M10.1%
Top 3 weight
89.9%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 24.30M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
24.30M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other8
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings8
Rows:
RayzeBio, Inc.
OTRShares5.16M
TypeSH
Market value$114.51M
60.87%
Sole
0.00
Shared
5.16M
None
0.00
Repare Therapeutics, Inc.
OTRShares2.65M
TypeSH
Market value$31.97M
17.00%
Sole
0.00
Shared
2.65M
None
0.00
CRISPR Therapeutics AG
OTRShares498.56K
TypeSH
Market value$22.63M
12.03%
Sole
0.00
Shared
498.56K
None
0.00
Adverum Biotechnologies, Inc.
OTRShares5.07M
TypeSH
Market value$7.60M
4.04%
Sole
0.00
Shared
5.07M
None
0.00
Gritstone Oncology, Inc.
OTRShares3.56M
TypeSH
Market value$6.13M
3.26%
Sole
0.00
Shared
3.56M
None
0.00
Passage Bio, Inc.
OTRShares4.96M
TypeSH
Market value$3.26M
1.73%
Sole
0.00
Shared
4.96M
None
0.00
Aligos Therapeutics, Inc.
OTRShares2.32M
TypeSH
Market value$1.73M
0.92%
Sole
0.00
Shared
2.32M
None
0.00
Minerva Surgical Inc.
OTRShares83.68K
TypeSH
Market value$275.3K
0.15%
Sole
0.00
Shared
83.68K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
RayzeBio, Inc.OTR | Common Stock | 5.16M | SH | $114.51M 60.87% | 0.00 | 5.16M | 0.00 |
Repare Therapeutics, Inc.OTR | Common Stock | 2.65M | SH | $31.97M 17.00% | 0.00 | 2.65M | 0.00 |
CRISPR Therapeutics AGOTR | Common Shares | 498.56K | SH | $22.63M 12.03% | 0.00 | 498.56K | 0.00 |
Adverum Biotechnologies, Inc.OTR | Common Stock | 5.07M | SH | $7.60M 4.04% | 0.00 | 5.07M | 0.00 |
Gritstone Oncology, Inc.OTR | Common Stock | 3.56M | SH | $6.13M 3.26% | 0.00 | 3.56M | 0.00 |
Passage Bio, Inc.OTR | Common Stock | 4.96M | SH | $3.26M 1.73% | 0.00 | 4.96M | 0.00 |
Aligos Therapeutics, Inc.OTR | Common Stock | 2.32M | SH | $1.73M 0.92% | 0.00 | 2.32M | 0.00 |
Minerva Surgical Inc.OTR | Common Stock | 83.68K | SH | $275.3K 0.15% | 0.00 | 83.68K | 0.00 |